Dr Reddy’s Must Notify Celgene Of Plans To Sell Revlimid Generic In Australia
Three-Month Notice Period Will Give Originator The Opportunity To Seek An Injunction
Dr Reddy's until 28 January 2022 to file and serve its defense and any cross-claim • Source: Alamy 
